PL1951759T3 - Przeciwciała anty-EGFR - Google Patents

Przeciwciała anty-EGFR

Info

Publication number
PL1951759T3
PL1951759T3 PL06837044T PL06837044T PL1951759T3 PL 1951759 T3 PL1951759 T3 PL 1951759T3 PL 06837044 T PL06837044 T PL 06837044T PL 06837044 T PL06837044 T PL 06837044T PL 1951759 T3 PL1951759 T3 PL 1951759T3
Authority
PL
Poland
Prior art keywords
egfr antibodies
egfr
antibodies
Prior art date
Application number
PL06837044T
Other languages
English (en)
Inventor
Catherine Brautigam Beidler
Alain Philippe Vasserot
Jeffry Dean Watkins
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority claimed from PCT/US2006/043311 external-priority patent/WO2007058823A2/en
Publication of PL1951759T3 publication Critical patent/PL1951759T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2863Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for growth factors, growth regulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/46Hybrid immunoglobulins
    • C07K16/461Igs containing Ig-regions, -domains or -residues form different species
    • C07K16/464Igs containing CDR-residues from one specie grafted between FR-residues from another
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/505Medicinal preparations containing antigens or antibodies comprising antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/21Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/20Immunoglobulins specific features characterized by taxonomic origin
    • C07K2317/24Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55Fab or Fab'
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/50Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C07K2317/565Complementarity determining region [CDR]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/70Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C07K2317/76Antagonist effect on antigen, e.g. neutralization or inhibition of binding
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/90Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C07K2317/92Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
PL06837044T 2005-11-12 2006-11-06 Przeciwciała anty-EGFR PL1951759T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73536305P 2005-11-12 2005-11-12
EP06837044A EP1951759B1 (en) 2005-11-12 2006-11-06 Anti-egfr antibodies
PCT/US2006/043311 WO2007058823A2 (en) 2005-11-12 2006-11-06 Anti-egfr antibodies

Publications (1)

Publication Number Publication Date
PL1951759T3 true PL1951759T3 (pl) 2010-07-30

Family

ID=42664730

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06837044T PL1951759T3 (pl) 2005-11-12 2006-11-06 Przeciwciała anty-EGFR

Country Status (3)

Country Link
EP (1) EP1951759B1 (pl)
PL (1) PL1951759T3 (pl)
SI (1) SI1951759T1 (pl)

Also Published As

Publication number Publication date
EP1951759B1 (en) 2010-03-17
SI1951759T1 (sl) 2010-08-31
EP1951759A2 (en) 2008-08-06

Similar Documents

Publication Publication Date Title
HK1218126A1 (zh) 抗體
HRP20150176T1 (en) Anti-myostatin antibodies
IL181575A0 (en) Anti-ox40l antibodies
IL228033A0 (en) Antibodies
IL189579A0 (en) Anti-myostatin antibodies
IL187106A (en) Sclerostin binds antibody
IL190472A0 (en) Anti-glypican-3 antibody
IL185366A0 (en) Antibody
GB0517487D0 (en) Antibodies
GB0420466D0 (en) Anti-glucan antibodies
ZA200701952B (en) Anti-OX40L antibodies
EP1896047A4 (en) ANTI-GFRALPHA3 ANTIBODIES
GB0505489D0 (en) Antibodies
GB0512278D0 (en) Antibodies
GB0505054D0 (en) Antibodies
PL1951759T3 (pl) Przeciwciała anty-EGFR
GB0519883D0 (en) Antibodies
GB0402642D0 (en) Antibodies
GB0402641D0 (en) Antibodies
GB0506945D0 (en) Human antibodies
GB0502201D0 (en) Human antibodies
GB0503190D0 (en) Human antibodies
GB0413479D0 (en) Novel antibodies
GB0500400D0 (en) Antibody